Bill Text: TX HB3152 | 2023-2024 | 88th Legislature | Introduced

---

Bill Title: Relating to the identification of the country of manufacture on the label for a prescription drug or biological product.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2023-03-15 - Referred to Public Health [HB3152 Detail]

Download: Texas-2023-HB3152-Introduced.html

---

88R9626 SHH-D
By: Price H.B. No. 3152

A BILL TO BE ENTITLED
AN ACT
relating to the identification of the country of manufacture on the
label for a prescription drug or biological product.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 562.006, Occupations Code, is amended by
adding Subsection (a-1) and amending Subsection (b) to read as
follows:
(a-1) The label on the dispensing container on a drug or
biological product dispensed by a pharmacy must indicate the
country where the drug or biological product was manufactured.
(b) In addition to the information required by Subsections
[Subsection] (a) and (a-1), the label on the dispensing container
of a drug or biological product dispensed by a Class A or Class E
pharmacy must indicate:
(1) the name, address, and telephone number of the
pharmacy;
(2) the date the prescription is dispensed;
(3) the name of the prescribing practitioner;
(4) the name of the patient or, if the drug or
biological product was prescribed for an animal, the species of the
animal and the name of the owner;
(5) instructions for use;
(6) the quantity dispensed;
(7) if the drug or biological product is dispensed in a
container other than the manufacturer's original container, the
date after which the prescription should not be used, determined
according to criteria established by board rule based on standards
in the United States Pharmacopeia-National Formulary; and
(8) any other information required by board rule.
SECTION 2. The Texas State Board of Pharmacy shall adopt any
rules necessary to implement Section 562.006(a-1), Occupations
Code, as added by this Act, not later than January 1, 2024.
SECTION 3. The change in law made by this Act applies only
to a drug or biological product dispensed on or after March 1, 2024.
A drug or biological product dispensed before March 1, 2024, is
governed by the law in effect immediately before the effective date
of this Act, and the former law is continued in effect for that
purpose.
SECTION 4. This Act takes effect September 1, 2023.